This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Taipei Medical University. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Yu-Hsun Kao: Innovator in Heart Failure Treatment
Introduction
Yu-Hsun Kao is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of medicine, particularly in the treatment of heart failure and neuronal injury. His innovative approach utilizes small molecules to develop effective therapeutic solutions.
Latest Patents
Yu-Hsun Kao holds a patent titled "Use of indolyl and indolinyl hydroxamates for treating heart failure of neuronal injury." This patent discloses the novel use of indolyl and indolinyl hydroxamates as lead compounds for manufacturing a medicament or pharmaceutical composition aimed at treating patients suffering from heart failure or neuronal injury. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Yu-Hsun Kao is affiliated with Taipei Medical University, where he continues to engage in research and development. His work focuses on creating innovative solutions that address critical health issues, particularly in cardiology and neurology.
Collaborations
Some of his notable coworkers include Yi-Jen Chen and Kuo-Sheng Hung, who contribute to his research endeavors and help foster a collaborative environment for innovation.
Conclusion
Yu-Hsun Kao's contributions to the medical field through his patent and research at Taipei Medical University highlight his dedication to improving patient outcomes in heart failure and neuronal injury. His work exemplifies the impact of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile